Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline effects on CRP and depression in hemodialysis
NCT06840379Active, not recruiting
- Sponsor
- Nishtar Medical University
- Start
- Oct 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in major depressive disorder (MDD) and inflammation comparing Sertraline Group with Placebo Group (2 arms). Primary endpoint: Mean Change in Serum C-Reactive Protein at 12 weeks. Started Oct 2024; status: active, not recruiting.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)inflammation
Beyond the preview
Go deeper on NCT06840379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06840379.